Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths - FDA Press Releases

FDA describes unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths

from Food and Drug Administration--Press Releases http://bit.ly/2FFpqzt
via IFTTT